© Copyright 2022 Cedars Sinai Precision Biomarker Laboratories
Release The Power Of
What We Do
From biomarker discovery to commercialization, we are here to meet your needs.
Our experts customize individual services or integrated solutions across biomarker discovery, validation and CAP/CLIA-certified laboratory testing capabilities to provide you with targeted data that advances your specific product goals.
Global Proteomics Discovery
Proteomics Contract Research
- Early research and discovery
- Offers menu of ready-to-go clinically relevant targeted biomarkers
- Leverages mass spectrometry technology and expertise
- Translation of medical discoveries into clinical products
- Investigators access:
- Clinical expertise
- Advanced technology platforms
- Clinical cohorts
- Bioinformatics infrastructure, data analysis
Accelerate your breakthrough
drugs and diagnostics
The value of proteomics: It's about time.
Unlike the genome, the proteome changes over time. It not only serves as a signature of current physiological status in response to multiple perturbations, but also offers relevant insights into targets for therapeutic intervention.
Proteomics or the analysis of the proteome lies downstream of genetic and epigenetic factors that contribute to disease risk and upstream of biochemical changes, making it well positioned to contribute to discoveries in precision medicine
What we do
Propelling proteomics with mass spectrometry
Mass spectrometry-based proteomics enables efficient development of high throughput assays for precise characterization and quantitation of proteins.